276 related articles for article (PubMed ID: 23800676)
1. Arsenic exposure and cancer mortality in a US-based prospective cohort: the strong heart study.
García-Esquinas E; Pollán M; Umans JG; Francesconi KA; Goessler W; Guallar E; Howard B; Farley J; Best LG; Navas-Acien A
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1944-53. PubMed ID: 23800676
[TBL] [Abstract][Full Text] [Related]
2. The association of urine arsenic with prevalent and incident chronic kidney disease: evidence from the Strong Heart Study.
Zheng LY; Umans JG; Yeh F; Francesconi KA; Goessler W; Silbergeld EK; Bandeen-Roche K; Guallar E; Howard BV; Weaver VM; Navas-Acien A
Epidemiology; 2015 Jul; 26(4):601-12. PubMed ID: 25929811
[TBL] [Abstract][Full Text] [Related]
3. Cadmium exposure and cancer mortality in a prospective cohort: the strong heart study.
García-Esquinas E; Pollan M; Tellez-Plaza M; Francesconi KA; Goessler W; Guallar E; Umans JG; Yeh J; Best LG; Navas-Acien A
Environ Health Perspect; 2014 Apr; 122(4):363-70. PubMed ID: 24531129
[TBL] [Abstract][Full Text] [Related]
4. Arsenic Exposure, Arsenic Metabolism, and Incident Diabetes in the Strong Heart Study.
Kuo CC; Howard BV; Umans JG; Gribble MO; Best LG; Francesconi KA; Goessler W; Lee E; Guallar E; Navas-Acien A
Diabetes Care; 2015 Apr; 38(4):620-7. PubMed ID: 25583752
[TBL] [Abstract][Full Text] [Related]
5. Arsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study.
Gribble MO; Howard BV; Umans JG; Shara NM; Francesconi KA; Goessler W; Crainiceanu CM; Silbergeld EK; Guallar E; Navas-Acien A
Am J Epidemiol; 2012 Nov; 176(10):865-74. PubMed ID: 23097256
[TBL] [Abstract][Full Text] [Related]
6. Cadmium exposure and incident cardiovascular disease.
Tellez-Plaza M; Guallar E; Howard BV; Umans JG; Francesconi KA; Goessler W; Silbergeld EK; Devereux RB; Navas-Acien A
Epidemiology; 2013 May; 24(3):421-9. PubMed ID: 23514838
[TBL] [Abstract][Full Text] [Related]
7. Association between exposure to low to moderate arsenic levels and incident cardiovascular disease. A prospective cohort study.
Moon KA; Guallar E; Umans JG; Devereux RB; Best LG; Francesconi KA; Goessler W; Pollak J; Silbergeld EK; Howard BV; Navas-Acien A
Ann Intern Med; 2013 Nov; 159(10):649-59. PubMed ID: 24061511
[TBL] [Abstract][Full Text] [Related]
8. Urine arsenic concentrations and species excretion patterns in American Indian communities over a 10-year period: the Strong Heart Study.
Navas-Acien A; Umans JG; Howard BV; Goessler W; Francesconi KA; Crainiceanu CM; Silbergeld EK; Guallar E
Environ Health Perspect; 2009 Sep; 117(9):1428-33. PubMed ID: 19750109
[TBL] [Abstract][Full Text] [Related]
9. Chronic arsenic exposure and risk of carotid artery disease: The Strong Heart Study.
Mateen FJ; Grau-Perez M; Pollak JS; Moon KA; Howard BV; Umans JG; Best LG; Francesconi KA; Goessler W; Crainiceanu C; Guallar E; Devereux RB; Roman MJ; Navas-Acien A
Environ Res; 2017 Aug; 157():127-134. PubMed ID: 28554006
[TBL] [Abstract][Full Text] [Related]
10. All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45-74 years, 1984-1988. The Strong Heart Study.
Lee ET; Cowan LD; Welty TK; Sievers M; Howard WJ; Oopik A; Wang W; Yeh J; Devereux RB; Rhoades ER; Fabsitz RR; Go O; Howard BV
Am J Epidemiol; 1998 Jun; 147(11):995-1008. PubMed ID: 9620042
[TBL] [Abstract][Full Text] [Related]
11. The association of arsenic exposure and arsenic metabolism with all-cause, cardiovascular and cancer mortality in the Strong Heart Study.
Kuo CC; Balakrishnan P; Gribble MO; Best LG; Goessler W; Umans JG; Navas-Acien A
Environ Int; 2022 Jan; 159():107029. PubMed ID: 34890900
[TBL] [Abstract][Full Text] [Related]
12. Urine arsenic and prevalent albuminuria: evidence from a population-based study.
Zheng LY; Umans JG; Tellez-Plaza M; Yeh F; Francesconi KA; Goessler W; Silbergeld EK; Guallar E; Howard BV; Weaver VM; Navas-Acien A
Am J Kidney Dis; 2013 Mar; 61(3):385-94. PubMed ID: 23142528
[TBL] [Abstract][Full Text] [Related]
13. Arsenic, blood pressure, and hypertension in the Strong Heart Family Study.
Kaufman JA; Mattison C; Fretts AM; Umans JG; Cole SA; Voruganti VS; Goessler W; Best LG; Zhang Y; Tellez-Plaza M; Navas-Acien A; Gribble MO
Environ Res; 2021 Apr; 195():110864. PubMed ID: 33581093
[TBL] [Abstract][Full Text] [Related]
14. Cadmium exposure and incident peripheral arterial disease.
Tellez-Plaza M; Guallar E; Fabsitz RR; Howard BV; Umans JG; Francesconi KA; Goessler W; Devereux RB; Navas-Acien A
Circ Cardiovasc Qual Outcomes; 2013 Nov; 6(6):626-33. PubMed ID: 24255048
[TBL] [Abstract][Full Text] [Related]
15. Peripheral Arterial Disease and Its Association With Arsenic Exposure and Metabolism in the Strong Heart Study.
Newman JD; Navas-Acien A; Kuo CC; Guallar E; Howard BV; Fabsitz RR; Devereux RB; Umans JG; Francesconi KA; Goessler W; Best LT; Tellez-Plaza M
Am J Epidemiol; 2016 Dec; 184(11):806-817. PubMed ID: 27810857
[TBL] [Abstract][Full Text] [Related]
16. Association of Arsenic Exposure With Cardiac Geometry and Left Ventricular Function in Young Adults.
Pichler G; Grau-Perez M; Tellez-Plaza M; Umans J; Best L; Cole S; Goessler W; Francesconi K; Newman J; Redon J; Devereux R; Navas-Acien A
Circ Cardiovasc Imaging; 2019 May; 12(5):e009018. PubMed ID: 31060373
[TBL] [Abstract][Full Text] [Related]
17. Arsenic exposure and prevalence of type 2 diabetes in US adults.
Navas-Acien A; Silbergeld EK; Pastor-Barriuso R; Guallar E
JAMA; 2008 Aug; 300(7):814-22. PubMed ID: 18714061
[TBL] [Abstract][Full Text] [Related]
18. Use of arsenic-induced palmoplantar hyperkeratosis and skin cancers to predict risk of subsequent internal malignancy.
Hsu LI; Chen GS; Lee CH; Yang TY; Chen YH; Wang YH; Hsueh YM; Chiou HY; Wu MM; Chen CJ
Am J Epidemiol; 2013 Feb; 177(3):202-12. PubMed ID: 23299695
[TBL] [Abstract][Full Text] [Related]
19. Rising tide of cardiovascular disease in American Indians. The Strong Heart Study.
Howard BV; Lee ET; Cowan LD; Devereux RB; Galloway JM; Go OT; Howard WJ; Rhoades ER; Robbins DC; Sievers ML; Welty TK
Circulation; 1999 May; 99(18):2389-95. PubMed ID: 10318659
[TBL] [Abstract][Full Text] [Related]
20. Body composition and arsenic metabolism: a cross-sectional analysis in the Strong Heart Study.
Gribble MO; Crainiceanu CM; Howard BV; Umans JG; Francesconi KA; Goessler W; Zhang Y; Silbergeld EK; Guallar E; Navas-Acien A
Environ Health; 2013 Dec; 12():107. PubMed ID: 24321145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
